BMS-986449
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BMS-986449, covering 2025-06-11 to 2025-06-11. Get the full timeline:
Most recent: Clinical Trial Update: A Study of BMS-986449 With and Without Nivolumab in Participants With Advanced Solid Tumors [Phase 1, Phase 2]